AI481877 is a molecular entity that has been identified and characterized within the realm of cellular biology and biochemistry. Like many molecular entities, its significance arises from its role in specific cellular or physiological processes. Whether AI481877 functions in signaling pathways, enzymatic reactions, protein-protein interactions, or other cellular activities, understanding its precise role is pivotal for grasping its cellular importance and its potential as a target for inhibition.
Inhibitors targeting AI481877 are chemical compounds or molecules designed to modulate, often with the aim of reducing or completely blocking, the activity or expression of AI481877 in cellular processes. The design and synthesis of these inhibitors are based on a deep understanding of the molecular structure and function of AI481877. If AI481877 functions as an enzyme, for example, inhibitors might be tailored to obstruct its active site or induce a conformational change that renders it inactive. If AI481877 operates by binding to other proteins or molecules, inhibitors could be structured to prevent such interactions. This could be achieved by either mimicking the natural binding partners of AI481877 or by inducing changes in its structure that negate its binding capability. The precision in designing these inhibitors is crucial; they must be specific to AI481877 to minimize unintended interactions with other molecules, which could lead to undesirable cellular outcomes. In essence, the development and study of AI481877 inhibitors underscore the intricate dance of molecular biology, where understanding one player's steps can lead to the choreography of an entire performance. The study and development of these inhibitors not only expand our understanding of cellular biology but also open doors to potential applications in various fields of research and industry.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, which might have off-target effects on genes involved in DNA repair and recombination, including SHOC1. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate is an inhibitor of dihydrofolate reductase, affecting DNA synthesis. It might impact genes involved in DNA repair, including SHOC1. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which may influence various cellular pathways, including those affecting DNA repair and potentially SHOC1 expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide targets topoisomerase II, and its influence on DNA structure might affect SHOC1 expression indirectly. | ||||||
Bleomycin Sulfate | 9041-93-4 | sc-200134 sc-200134A sc-200134B sc-200134C | 10 mg 50 mg 100 mg 500 mg | $206.00 $612.00 $1020.00 $2856.00 | 38 | |
Bleomycin causes DNA damage, which may influence the expression of DNA repair genes, potentially including SHOC1. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $311.00 | ||
Flavopiridol inhibits cyclin-dependent kinases and might influence the cell cycle and related proteins, including SHOC1. | ||||||
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $35.00 $86.00 $216.00 $427.00 | 8 | |
Mimosine is a cell cycle inhibitor, and its action might impact the expression of genes associated with DNA replication and repair, potentially affecting SHOC1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor, which could influence protein degradation and potentially SHOC1 stability and expression. | ||||||
Topotecan | 123948-87-8 | sc-338718 | 100 mg | $571.00 | ||
Topotecan inhibits topoisomerase I, potentially influencing DNA structure and genes involved in DNA repair, including SHOC1. | ||||||
Amsacrine hydrochloride | 54301-15-4 | sc-214540 | 10 mg | $232.00 | ||
Amsacrine affects topoisomerase II and DNA structure, which might have off-target effects on SHOC1 expression. |